Background: Near-infrared spectroscopy, a non-invasive technique for monitoring cerebral oxygenation, is widely used, but its accuracy is questioned because of the possibility of extra-cranial contamination. Ultrasound-tagged near-infrared spectroscopy (UT-NIRS) has been proposed as an improvement over previous methods. We investigated UT-NIRS in healthy volunteers and in brain-dead patients. Methods: We studied 20 healthy volunteers and 20 brain-dead patients with two UT-NIRS devices, CerOx™ and c-FLOW™ (Ornim Medical, Kfar Saba, Israel), which measure cerebral flow index (CFI), a parameter related to changes in cerebral blood flow (CBF). Monitoring started after the patients had been declared brain dead for a median of 34 (range: 11e300) min. In 11 cases, we obtained further demonstration of absent CBF. Results: In healthy volunteers, CFI was markedly different in the two hemispheres in the same subject, with wide variability amongst subjects. In brain-dead patients (median age: 64 yr old, 45% female; 20% traumatic brain injury, 40% subarachnoid haemorrhage, and 40% intracranial haemorrhage), the median (inter-quartile range) CFI was 41 (36e47), significantly higher than in volunteers (33; 27e36). Conclusions: In brain-dead patients, where CBF is absent, the UT-NIRS findings can indicate an apparently perfused brain. This might reflect an insufficient separation of signals from extra-cranial structures from a genuine appraisal of cerebral perfusion. For non-invasive assessment of CBF-related parameters, the near-infrared spectroscopy still needs substantial improvement.
Keywords: brain death; brain monitoring; cerebral blood flow; near-infrared spectroscopy; ultrasound-tagged nearinfrared spectroscopy Non-invasive neuromonitoring tools without risk of brain damage are advantageous. Near-infrared spectroscopy (NIRS), a system that emits near-infrared light and detects the returning light that has passed through extra-cranial and cerebral tissues, has been widely used for decades for measuring haemoglobin saturation in cerebral tissue. 1e4 Its validity in adults, however, has been questioned, mainly because of risk of extra-cranial contamination.
2,5e7
Conventional NIRS extracts regional oxygen saturation in tissue by analysing the attenuation of light by oxygenated and deoxygenated haemoglobin within the microvasculature underneath the probe. 1 This analysis involves measuring the intensity of light backscattered from tissue using at least two wavelengths (commonly one wavelength is below and another is above 800 nm). Changes in regional oxygen saturation in the volume illuminated by the light are calculated from the intensity of light reaching two detectors using the BeereLambert law and spatially resolved spectroscopy. 1 Ultrasound-tagged NIRS (UT-NIRS), introduced recently, combines NIRS and ultrasound, aiming at selective detection of the signal originating from changes in light passing through grey matter. Unlike conventional NIRS, UT-NIRS assesses localised Doppler broadening of coherent light at a single wavelength (808 nm) around the ultrasound frequency as a measure for changes in microvascular blood flow. 8 This technology is more closely related to laser Doppler flowmetry 9 than to conventional NIRS, as it does not calculate regional oxygen saturation. Unlike laser Doppler, the broadening is assessed around the frequency of the ultrasound wave, which is used to modulate the light (around 1 MHz). Therefore, UT-NIRS provides a regional measure of changes in blood flow underneath the sensor. Earlier versions of the technology were tested in animal models, and found to correspond to laser Doppler readings during haemodynamic manipulations. 10 The broadening is calculated in arbitrary units (0e100), so the results are provided without calibration and do not reflect the absolute quantity of blood flow underneath the sensor. To what extent UT-NIRS technology focuses better on intracerebral signals requires confirmation. Brain death is a condition of irreversible loss of brain function as a result of cessation of circulation in structures cranial to the foramen magnum. Different criteria are used to define patients as brain dead depending on national legislation, but global, complete, and irreversible brain ischaemia is a defining feature. We examined whether UT-NIRS properly detects the absence of cerebral blood flow (CBF) in brain-dead patients in comparison to healthy volunteers.
Methods
Data were collected from February 2014 to June 2017 at the Neurointensive Care Unit, and the study was approved by the Ethics Committee of the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Healthy volunteers signed a consent form, whilst for the subset of patients declared brain dead no consent was sought, because the Ethics Committee agreed that a purely observational data collection in brain-death cases did not require specific consent. Families were informed, but no consent form was used.
Noninvasive CBF
Cerebral perfusion was measured with UT-NIRS using the CerOx™ device (Ornim Medical, Kfar Saba, Israel) up until December 2015, when a new model (c-FLOW™; Ornim Medical) became available. In February 2016, the c-FLOW software was upgraded to a later version. As claimed by the manufacturer, 'this technology allows a noninvasive and continuous check of deep tissue blood flow used to measure relative changes in blood flow that monitors regional microcirculatory blood flow in tissues'. 11 The device, connected to two probes, displays cerebral flow index (CFI) as a 'pure' number that ranges from 0 to 100. The normal CFI range is not known, and the manufacturer suggests considering relative changes in blood flow rather than absolute numbers. Each probe illuminates tissue of the right or left cerebral lobe with laser light, and collects light scattered back. The probes also incorporate a small ultrasound transducer that provides low-power waves to induce the UT-NIRS signal, 12 and the monitors display an indicator of the signal quality. Preparation of subjects (volunteer or patient) and set-up of the device were completed according to the c-FLOW User Manual. 13 After selecting a flat, intact, hairless area on the forehead, cleaned with sterile alcohol wipes, two disposable adhesive pads (Smart Pads, supplied by Ornim) were applied, one on the right and one on the left. With care to avoid creating air bubbles, we applied a small amount of ultrasound gel to the UT-NIRS probes, which were then firmly pressed onto the adhesive pads. During the first measurements on volunteers, an Ornim representative supervised the placement of the frontal probes and correct set-up of the machine. For healthy volunteers, data from the UT-NIRS were acquired for variable lengths of time (15e20 min) after having obtained a
Editor's key points
Near-infrared spectroscopy (NIRS) is a widely used noninvasive technique for monitoring cerebral oxygenation, but its accuracy may be impaired by extracranial contamination. Ultrasound-tagged near-infrared spectroscopy (UT-NIRS), which has been proposed as an improvement over previous methods, was studied in 20 healthy volunteers and 20 brain-dead patients. Two devices tested both showed inter-hemispheric differences in cerebral flow index, a parameter related to cerebral blood flow, and higher values in brain-dead patients than in volunteers. Further refinements are necessary to make NIRS a reliable technique for monitoring cerebral perfusion free of extracranial interference. stable value with full signal quality. Peripheral capillary oxygen saturation, end-tidal CO 2 , respiration rate, and cardiac frequency were recorded, and data stored for analysis. In brain-dead patients, UT-NIRS data acquisition started after the criteria for brain death had been fulfilled and after obtaining a good-quality signal from the device. At the beginning of this investigation, UT-NIRS measurement was continued for several hours (up to 6 h) to verify stability of the CFI. Measurements in the first five cases were consistent and stable, so the duration of monitoring was reduced, and the median recording time for all brain-dead patients was 34 min. All data were acquired directly from the Ornim devices in digital format and archived. In consideration of the stability of the data, two values were recorded for each patient with an interval of 5 min, and used for the analysis.
Diagnosis of brain death
The study was conducted on ICU patients with acute brain damage (Table 1) after they had been declared brain dead. Brain death, defined as the irreversible cessation of all brain functions, is regulated by law in Italy. A patient is declared brain dead by a panel of three doctors who must verify the simultaneous presence of the following: (i) evidence of brain lesions consistent with deep coma (Glasgow Coma Scale 3); (ii) absence of confounding factors, such as hypothermia, sedatives, myorelaxants, acute electrolyte abnormalities, etc.; (iii) absence of brainstem reflexes; (iv) apnoea (absence of respiratory drive with arterial Pco 2 8 kPa and pH 7.4); and (v) electroencephalography documenting the absence of spontaneous or induced brain electric activity.
All these criteria are first measured by the panel, and then reassessed after 6 h of observation.
In a subset of brain-dead patients, we recorded the transcranial colour Doppler (TCCD), angio-CT scan, or brain angiography to confirm the absence of CBF further.
Statistical analysis
Data were not normally distributed, and non-parametric methods were applied using Prism 6.00 software (GraphPad, San Diego, CA, USA). When not otherwise specified, data are summarised as median with inter-quartile range. We used the Wilcoxon test to analyse differences between the two recording sides (right and left frontal lobes). To compare CFI from healthy volunteers and brain-dead patients, and to analyse the differences between the two devices (CerOx and c-FLOW), we used the ManneWhitney test. When necessary, the BlandeAltman method was applied. 14 
Results

Healthy volunteers
Of the 20 healthy volunteers monitored with UT-NIRS, eight were studied with the CerOx and 12 with the c-FLOW. The median age was 26 (25e34) yr and 45% were males. The signal quality was adequate in all subjects and all recordings proceeded uneventfully, giving a median CFI of 33 (27e36). The distribution of CFI values is shown in Fig. 1 , which also illustrates the BlandeAltman plot of the differences (mean difference e4.5; standard deviation: 11.95). A separate analysis of data recorded with the two UT-NIRS models did not indicate any pattern related to the model. Both models documented important intra-patient CFI differences, irrespective of the software version used.
Brain-dead patients
For the 20 brain-dead patients studied, the median age was 60 (54e76) yr and 11 were males. The cause of brain death was traumatic brain injury (20%), subarachnoid haemorrhage (40%), and intracranial haemorrhage in the remaining 40%. One required a decompressive hemicraniectomy, and the data for this case were analysed separately. CerOx was used in five patients and c-FLOW in 15. Measurements were taken after the patients fulfilled all criteria for diagnosis of brain death. Table 1 summarises the main clinical features and specifies how the diagnosis of brain death was confirmed by additional investigations, such as TCCD, angio-CT scan, or angiography in 11 cases. UT-NIRS detected a positive CFI in all brain-dead patients, with a median of 41 (36e47), with no significant differences between the two probes in patients with intact skull (Wilcoxon test; P¼0.85).
All recordings had an adequate signal quality. No significant differences were detected between measurements taken with the CerOx or the c-FLOW device. Figure 2 illustrates a typical CFI recording, apparently indicative of normal CBF, in a representative case with concomitant absence of cerebral electrical activity and evidence of no CBF by angiography and angio-CT scan.
Comparison of healthy volunteers and brain-dead patients
UT-NIRS findings acquired in volunteers and brain-dead patients are compared in Fig. 4 . The CFI values in brain-dead patients were significantly higher than in healthy volunteers (ManneWhitney test; P<0.01).
Brain death patient with decompressive craniectomy
One patient was operated for unilateral decompressive craniectomy to deal with refractory intracranial hypertension. This patient, therefore, had the right side of his head anatomically normal, with an intact skull, whilst on the left the skull had been surgically removed (see Fig. 3 for an example of a CT scan). The probe corresponding to the intact skull gave a CFI of 53, whilst on the decompressed side it was 0.
Discussion
Non-invasive assessment of parameters related to cerebral perfusion (such as CBF or cerebral oxygenation) would ensure substantial support for an accurate diagnosis and targeted interventions after acute brain damage. NIRS has been used for this purpose for decades in neurology, intensive care, and anaesthesia 15e19 despite concerns about its validity.
5e7, 20, 21 To validate the technique and collect normative data, we used UT-NIRS in young healthy volunteers. CFI values were widely distributed, and there were appreciable differences between the two hemispheres in the same subject. The mean difference, as shown in the BlandeAltman plot, was e4.5, but the limits of agreement ranged between e28.4 and þ19.4 for both the CerOx and the c-FLOW. In previous reports, only modest differences were noted between NIRS readings obtained with different techniques on the two sides of the forehead using two or more probes. 4, 20, 22, 23 Most papers, however, report averages rather than individual per-patient data. In general, these differences were felt to be unimportant, and their pathophysiological meaning has not been investigated. In patients declared brain dead, we consistently found higher CFI than in volunteers. Brain death was diagnosed in all cases by repeated neurological examination, including the apnoea test, and concomitant absence of brain electrical activity by EEG. Additional instrumental investigations, such as TCCD, cerebral angiography, and angio-CT scan, were also used in 11 cases; these confirmatory tests consistently excluded intracerebral blood flow. Despite these repeated confirmations of a condition where CBF should be absent, the CFI appeared 'normal', as shown in Fig.s 2 and 4 .
The contradictory finding of 'normal' cerebral oxygenation in the absence of CBF was first reported in 1994 by Germon and colleagues 24 who used an INVOS 3100 NIRS device in a patient with clinical signs of brain death after subarachnoid haemorrhage. EEG and TCCD were consistent with absence of cerebral perfusion, but the mean cerebral regional saturation appeared normal. Analogous findings were subsequently reported by several groups. 25e28 To solve this contradiction, some authors argued that, during brain death, oxygenated blood may be somehow compartmentalised in the brain, so that the NIRS assessment of normal oxygenation in a nonperfused brain could be correct. 2, 3, 29 This hypothesis, however, conflicts with several lines of evidence in animals and in a limited number of human reports. Brain death is the result of progressive global cerebral ischaemia, in which raised Evidence of complete ischaemia and disappearance of oxygen dissolved in brain tissue in brain death is compelling and raises concern about what exactly NIRS, even in the updated version of UT-NIRS, really measures. The most likely explanation of 'normal' saturation in the absence of brain circulation is that the NIRS probe may capture signals from extracerebral anatomical structures. Whilst in conditions of brain death the brain suffers complete circulatory arrest, all structures not exposed to raised intracranial pressure (such as the skull, muscles, skin, etc., perfused through the external carotid artery) may enjoy normal flow and oxygenation. If the light processed by NIRS in the forehead does not explore deep anatomical structures but only more superficial layers, normal data may have a reasonable explanation. This is further supported by our findings in the single subject with hemicraniectomy. UT-NIRS read normal data on the side with the intact bone, but could not detect CBF on the side where the bone had been removed. This is consistent with UT-NIRS detecting signals from superficial tissue layers a few centimetres thick. Whilst on the side not operated, this tissue volume included normally perfused structures; on the side of decompression, most of the signals could come from dead brain.
The contribution of extra-cerebral tissue to NIRS readings has been described. Scalp ischaemia induced by a pneumatic tourniquet in healthy volunteers reduced 'brain' oxygen saturation by NIRS in three separate series. 5, 7, 35 In those experiments, different NIRS devices were tested, and whilst there was a reduction in oxygenation in all cases, the extent of this reduction varied with the method. 7 An alternative exploration of extra-cranial contamination was attempted during vascular surgery with a carotid clamp in two papers. When the external carotid artery was temporarily clamped, the ipsilateral 'brain' saturation was minimally reduced in 34 patients in one report, 36 and more profoundly in a recent case report. 37 UT-NIRS has been engineered to analyse only light from a specific volume of tissue at an assigned depth, and provides a unitless value (CFI) that responds to changes in CBF. Unfortunately, our data indicate that, in an unequivocal condition of absent brain circulation in adults, corresponding to irreversible ischaemia and tissue deprivation of oxygen, UT-NIRS, at the present stage of development, provides numbers indistinguishable from those in healthy volunteers. This implies that CFI readings in brain-dead patients risk being interpreted as 'normal readings'.
A clear separation of intracranial signals from extracranial components is vital for NIRS to be valid. We are currently working with the UT-NIRS developer to refine the technology: a new algorithm that might separate surface from deeper flows better is in the process of validation. The absence of CBF during human brain death could provide a very clear condition where all near infrared signals associated with oxygenated blood cannot come from the brain, and as such should be identified and excluded. Only when this goal is achieved will credible non-invasive investigation of absolute brain perfusion by NIRS-based devices become feasible.
